163318	1975	evaluation dye exclusion colony inhibition technique detection polyoma specific cell mediate immunity cellular immunity direct polyoma virus induced antigen observe c3h hej splenic lymphoid cell ncbitaxon10090 sensitize short term immunization schedule syngeneic polyoma 4198 4198v meshd009369 cell polyoma specificity response show demonstration splenic cell dba 2j animal meshd014412 cytotoxic c3h 4198 4198v cell cell another cell line c3h origin polyoma specific response syngeneic system detectable dye exclusion assay colony inhibition procedure colony inhibition cell observe sensitize lymphoid cell allogeneic syngeneic system
163319	1975	potentiation ncbitaxon10515 associate virus ncbitaxon10310 transform cell ncbitaxon10310 ncbitaxon10310 transform cell line 333 8 9 inoculate adeno virus associate virus type 3 aav 3 examine immunofluorescent fa technique evidence aav 3 antigen synthesis antiserum prepared three meshd012967 dissociate structural polypeptide vp 1 vp 2 vp 3 aav 3 whole aav 3 virion use probe search aav 3 fa stainable antigen synthesize cell 333 8 9 cell inoculate aav 3 alone produced fa stainable antigen detect vp 1 vp 3 whole virion antiserum vp 2 antiserum coinfection aav 3 inoculated 333 8 9 cells with either ncbitaxon10515 ncbitaxon10515 ncbitaxon10298 ncbitaxon10298 helper permit formation fa stainable antigen detect antiserum include vp 2 antiserum contrast 333 8 9 cell bhk 21 cell fail produce aav 3 fa stainable antigen inoculate aav 3 alone addition either ncbitaxon10515 ncbitaxon10298 helper lead formation antigen detect vp whole virion antiserum result suggest 333 8 9 cell enhance formation two three aav 3 structural polypeptide incomplete potentiation related ncbitaxon10310 genetic material possess cell
163320	1975	biochemical property ncbitaxon1891767 transform 3t3 cell mitochondrion mitrochondria isolated ncbitaxon1891767 transform 3t3 nontransformed 3t3 cell compare various biochemical criterion transform nontransformed cell mitochondrion identical density linear meshd013395 discontinuous ncbitaxon9913 serum albumin gradient activity several mitochondrion specific enzyme include cytochrome oxidase adenylate kinase meshd009243 meshd009243 cytochrome reductase nadh oxidase similar cell type activity mitochondrial outer membrane enzyme monoamine oxidase virus transform cell mitochondrion reduce 50 nontransformed cell mitochondrion
163322	1975	cell origin meshd009369 induced ncbitaxon1891767 two meshd008223 induced ncbitaxon1891767 ncbitaxon1891767 ncbitaxon10036 analyze lymphocyte characteristic hymphocytes meshd009369 contain membrane bound ig exclusively 7sgamma2 class neither meshd009369 complement receptor meshd009369 oringinated particular cell population suggests cell type associate ncbitaxon1891767 receptor
163324	1975	elevate immunofluorescence antibody titer several herpesviruses meshd002051 patient high titer unique antibody titer viral capsid antigen four human herpesviruses measure immunofluorescence serum 16 meshd002051 bl patients 16 age sex and locality matched controls and 136 family members from the west nile district uganda among family member titer great 1 4 found 98 herpes simplex virus meshc536395 86 ncbitaxon10335 ncbitaxon10335 100 for cytomegalovirus cmv and 94 for meshd020031 ebv titer patient average approximately equal 2 log fourfold high match control ebv ncbitaxon10335 cmv equals 0 001 titer meshc536395 slightly high meshd009369 patient mother patient someuhat high ebv titer 0 05 small equal smaller than or equal to 0 01 mother control difference patient control family found immunofluorescence method apparently use four human herpesviruses bl patient patient elevate antibody titer ebv cmv ncbitaxon10335 elevate titer three four human herpesviruses due serologic cross reaction
163325	1975	unexpected high incidence meshd006528 geneva switzerland age standardize incidence rate meshd006528 plc geneva 9 7 per 100 000 male figure four five time high incidence rate report elsewhere europe plc often associate meshd005355 meshd000437 indicate toll plc related meshd000437 meshd008104 great anticipate
163326	1975	induction epstein barr virus associate nuclear antigen vitro transformation human lymphoid cell human lymphoid cell isolated peripheral blood adult cord blood fetal liver spleen bone marrow thymus cultivate cell free preparation epstein barr virus ncbitaxon10376 demonstrate transform activity culture examine ncbigene17494235 transfromation permanent lymphoblastoid cell line lcl ncbigene17494235 see culture receive exogenous ncbitaxon10376 detect day 1 6 addition ncbitaxon10376 frequently day 3 ncbigene17494235 positive cell lymphoblastoid appearance transformation establish lcl become apparent day 12 19 addition ncbitaxon3527 mitogen culture contain ncbitaxon10376 enhance development ncbigene17494235 whereas phytohemagglutinin concanavalin effect neither ncbigene17494235 transfomration observe lymphoid cell fetal thymus fetal spleen bone marrow liver cell ncbitaxon10376 regularly induced ncbigene17494235 lcl transformation
163327	1975	isolation tropic type virus reticulum cell meshd009369 induced balb ncbitaxon10090 sjl type virus d1 ncbitaxon11786 mulv tropic type virus isolated spontaneous meshd008228 type rcn sjl ncbitaxon10090 propagate nih swiss ncbitaxon10090 embryo cell culture inject balb ncbitaxon10090 1 day neonatal thymectomy 30 inoculate ncbitaxon10090 developed rcn 5 month whereas none uninoculated control spleen lymph node extract rcn bearing ncbitaxon10090 test tropic type virus designate e1 mulv isolated high titer 10 5 minus 10 6 xc plaque form unit ml low titer 10 1 minus 10 2 xc plaque form unit ml tropic virus isolated thymectomized ncbitaxon10090 inoculate nontumorous whereas tropic virus detect uninoculated thymectomized ncbitaxon10090 virus isolated nonthymectomized untreated control antigenically viral envelope antigen ncbigene12515 e1 mulv distinct du mulv xvea gross ncbigene12515 cross reaction akr mulv ncbigene12515 observe relationship d1 mulv e1 muvl respect oncogenesis viral genome activation discuss
163328	1975	chromosome aberration ncbitaxon10036 embryo cell transform exposure ultraviolet irradiate ncbitaxon10298 2 six ncbitaxon10036 embryo cell line 14 012 8 1 kos 6 1 333 8 9 333 2 29 ms 4 1 fr 6 1 developed exposure primary culture different strain uv irradiate herpes simplex virus hsv type 1 2 analyze chromosome aberration cell line show chromosome stability number chromosome maintain narrow range variation diploid region low incidence polyploid endoreduplications metaphase pulveration extensively fragment chromosome cell line passaged long period time vitro developed marker chromosome suggest clonal type evolution cell population two cell line 333 8 9 14 012 8 1 show two different marker chromosome large heterochromatic region chromosome abnormal heterochromatic region often appear like prominent secondary constriction found cell line examine level chromosome breakage low cell line except highly tumorigenic cell line 333 2 29 high incidence cell single double chromatinic body abnormal heterochromatic region occur marker chromosome prominent secondary constriction interpret possible chromosomal effect hsv karyotypic stability low incidence open break result uv irradiation hsv
163330	1975	blood group mn antigen precursor normal malignant human breast glandular tissue blood group active substance demonstrate human mammary gland tissue benign malignant lesion precursor thomsen friedenreich antigen occur meshd009369 tissue found regularly 15 gross meshd009369 test precursor tn antigen found regularly meshd009369 breast tissue antigen reactive breast meshd002278 antigen demonstrable 6 benign mammary gland study similarly tn antigen unmasked sialidase treatment healthy breast tissue anti antibody present human serum severely depressed many meshd001943 patient compare control
163331	1975	quantitative autoradiographic study nucleolus associate rna dna synthesis eclipse phase meshd001357 ncbitaxon9031 fibroblast functional morphologic difference sensitivity nucleolus ncbitaxon11886 transform cell newly infect cell action meshd003609 meshd000544 demonstrate quantitative light electron microscope autoradiography utilized investigate function nucleolus early stage meshd007239 pulse exposure low dos meshd000544 increase rna synthesis induced 80 minute fibrillar portion nucleolus meshd007239 concomitant increase retention tritiated meshd000544 nucleolus quantitative redistribution intranuclear cytoplasmic dna label interpret evidence virus induced amplification binding site meshd000544 nucleolar chromatin
163332	1975	effect ncbitaxon1891767 subcutaneous meshd009369 circulate meshd008055 lipoprotein ncbitaxon10036 circulate meshd008055 level lipoprotein pattern ncbitaxon10036 determine various time subcutaneous inoculation ncbitaxon1891767 ncbitaxon1891767 strain 2895 fortner meshd008545 cell ncbitaxon1891767 omim102510 induced rapid triphasic elevation serum total meshd008055 inhibition prebeta lipoprotein catabolism alpha lipoprotein level decline proportion meshd009369 mass liver wet weight total meshd008055 content increase significantly normal rate 3h glycerol incorporation meshc009791 precipitable prebeta serum lipoprotein maintain determination serum endogenous lipase lecithin cholesterol acyltransferase lcat cholinesterase activity indicate enzyme primarily responsible meshd009369 induced meshd006949 tumor bearing animal selectively increase rate protein meshd008055 excretion urine evidence gross hepatocellular meshd007674 growth ncbitaxon1891767 2895 meshd009369 hamster result large increase rate prebeta lipoprotein synthesis degradation circulate prebeta lipoprotein level elevate much later animal subsequent marked decrease lcat activity quite different result obtain meshd008545 even large meshd009369 moderate effect serum total meshd008055 level lipoprotein pattern ncbitaxon10036
163333	1975	inhibition cellular immune response ncbitaxon1891767 meshd009369 cell meshd009369 bearing meshd009369 immune ncbitaxon10090 concanavalin effect vivo administer concanavalin con kinetics primary secondary cellular immune response ncbitaxon1891767 transform meshd009369 cell investigate balb ncbitaxon10090 either single initial dose 400 mug con daily dos 50 mug depressed cell mediate immune response meshd009369 cell progressive growth meshd009369 determine radioisotopic foot pad assay immune meshd000275 correlate increase ultimate meshd009369 weight similarly con suppress antitumor cellular immune response meshd009369 immune animal immune reactivity return 6 day single injection 400 mug con continuous administration 50 mug con result gradual decline antitumor cellular immune responsiveness reach plateau 5th day splenic lymphocyte con treat immune ncbitaxon10090 fail elicit local adoptive transfer reaction immune responsiveness tend return incubation alpha methyl pyranosyl sugar
163334	1975	property ncbitaxon9031 lymphoblastoid cell line meshd008380 property ncbitaxon9031 lymphoblastoid cell line msb 1 meshd008380 study cell line grow well 41 degree medium rpmi 1640 supplement 10 ncbitaxon9913 fetal serum double time 8 12 hour cell grown stationary suspension culture attach vessel morphology typical lymphoblast 37 degree cell line grow initially cease divide several subculture subculture maintain 48 72 hour 1 2 cell produce ncbitaxon10390 ncbitaxon10390 specific intracellular mambrane antigen contain ncbitaxon39059 particle examine electron microscope cocultivation cell duck ncbitaxon9031 embryo fibroblast culture result meshc564591 production microplaques typical ncbitaxon10390 peripheral nerve lesion meshd009369 characteristic marek meshd010300 cause inoculation susceptible chick msb 1 cell duck cell infect strain bc 1 ncbitaxon10390 recover msb 1 cell line specific meshd009369 produce site inoculation meshd007239 readily transmit cagemates meshd009369 produce skeletal muscle seem largely virus induced msb 1 cell line free type virus particle
163335	1975	estrogen dependent vitro stimulation rna synthesis hormone dependent mammary meshd009369 ncbitaxon10116 incubation estradiol vitro 25 degree homogenate carcinogen induced mammary meshd009369 ovariectomized ncbitaxon10116 stimulate meshd008274 dependent rna polymerase activity nucleus hormone dependent meshd006816 regress meshd009369 effect activity nucleus hormone independent hi grow meshd009369 recombination nucleus cytosol fraction meshd006816 meshc538424 indicate vitro effect meshd004958 subsequent meshd009369 nuclear rna synthesis require ncbigene24890 contain cytosol specific nucleus meshd006816 constitute first direct vitro effect estrogen specific biochemical process meshd006816 mammary meshd009369
163336	1975	meshd008223 associate ncbitaxon10381 ncbitaxon9505 two case meshd008223 one case meshd008232 found group 7 ncbitaxon9505 import colony single group ncbitaxon10381 ncbitaxon10381 isolated meshd009369 cell 1 meshd008223 cocultivation kidney cell culture monkey meshd008232 antibody ncbitaxon10381 found serum sample 2 monkey positive ncbitaxon10381 serum 4 clinically normal monkey antibody meshd020031 cell found serum animal meshd008223
163337	1975	virus envelope marker mammalian tropism avian rna meshd009369 virus pseudotypes ncbitaxon11276 prepared avian meshd001357 represent five different subgroup pseudotypes display host range restrict avian meshd009369 virus assayed avian cell neutralize subgroup specific antiserum efficiency penetration mammalian cell assayed use ncbitaxon11276 pseudotypes pseudotypes avian meshd009369 virus belonging subgroup b77 virus able plate mammalian cell high efficiency whereas pseudotypes strain efficiency penetration ncbitaxon11276 pseudotypes 10 2 10 3 fold high efficiency transformation correspond avian meshd009369 virus strain assayed mammalian cell suggest postpenetration block expression transformation cell
163344	1975	rna synthesis cell infect herpes simplex virus ix evidence accumulation abundant symmetric transcript nucleus rna extract nucleus 8 infect cell drove approximately 50 herpes virus dna dna rna hybrid rna preannealed condition allow base pair take place drove 35 dna dna rna hybrid anneal rna diminish amount rna sequence remain available subsequent hybridization dna upon denaturation preannealed rna rna sequence sequester preannealing become available hybridization dna base pair occur preincubation rna inter molecular since rna concentration dependent affected limited alkaline hydrolysis nuclear viral transcript remain available hybridization preannealing rna subset rna sequence accumulate cytoplasm infect cell addition small amount derive 5 less viral dna complementary transcript detect cytoplasm
163347	1975	meshd003513 induction xenotropic type virus synchronize ncbitaxon10090 cell metabolic requirement virus activation information type rna virus genetically transmit cellular dna normal ncbitaxon10090 cell virus induced exposure cell two class chemical inhibitor protein synthesis halogenated meshd011743 metabolic requirement activation one endogenous virus balb ncbitaxon10090 cell representative class drug study meshd003513 meshd007065 induce virus efficiently culture exponential growth inactive cell stationary phase cell maximally sensitive action drug different time cell cycle virus induction response differentially inhibit condition simultaneous cell exposure inhibitor dna rna synthesis result provide support concept inhibitor protein synthesis halogenated meshd011743 act different mechanism induce type virus release
163363	1975	meshd001102 antigen synthesis modify meshd005166 cell transform t mutant ncbitaxon10090 cell transform t mutant meshd001102 t 3t3 low amount virus specific antigen synthesize high temperature 39 shift permissive temperature 31 cell exhibit level antigen production wild type polyoma transformants antigen produce t transform cell inactivate 39 vitro faster rate produce wild type transform cell observation indicate antigen include virus cod peptide
163364	1975	malignant transformation ncbitaxon10034 kidney cell ncbitaxon1891762 primary ncbitaxon10034 kidney cell transform ncbitaxon1891762 new human papovavirus transform hkbk cell produce ncbitaxon1891762 antigen induced meshd009369 hamster developed antibody ncbitaxon1891762 antigen ncbitaxon1891762 rescue hkbk cell ncbitaxon11191 assist fusion permissive cell one six cell line derive hkbk cell induced meshd009369 show characteristic hkbk cell
163369	1975	quantitative assay transformation 3t3 cell ncbitaxon10310 interaction ncbitaxon10298 hsv 1 type 2 ncbitaxon10310 swiss 3t3 cell investigate virus induced cytopathic effect developed absence production infectious virus ncbitaxon10310 inactivate uv light 2 4 6 8 min induced cell death absence virus replication cell death detectable infection ncbitaxon10310 inactivate uv irradiation 10 12 14 min 3t3 cell infect uv inactivate virus 10 12 min continued replicate past contact inhibit monolayer normally associate cell infection 3t3 cell uv irradiate usv 2 induced development transform focus transform cell epithelioid fibroblastoid morphology identify isolated ncbitaxon10310 transform cell line contain ncbitaxon10310 specific antigen detectable immunofluorescence technique maximum frequency ncbitaxon10310 induced transformation 3 time 105 pfu per transform focus observe transformation inhibit pretreatment virus specific antiserum type particle detect five cell culture passage transformation ncbitaxon10310 type virus particle detect 10 cell culture passage ncbitaxon10310 transform cell line
163372	1975	interspersion sequence ncbitaxon11866 rna rapidly hybridize meshd007938 ncbitaxon9031 cell dna liquid hybridization progressively small fragment 35s 27s 15 5s 12 5s 8s poly select ncbitaxon11866 rna excess dna meshd007938 ncbitaxon9031 myeloblast reveal size rna contain sequence complementary slowly rapidly hybridize cellular dna sequence apparently rna sequence hybridize rapidly excess cellular dna restrict one region ncbitaxon11866 35s rna instead appear randomly distribute entire 35s ncbitaxon11866 rna molecule position 200 nucleotide meshd011061 tract 3 end rna
163374	1975	ncbitaxon1891767 function require establishment maintenance malignant transformation member five class temperature sensitive ncbitaxon1891767 mutant test ability transform ncbitaxon10029 lung cell two criterion transformation use ability form clone medium low serum concentration ability overgrow monolayer mutant fail transform restrictive temperature subconfluent ncbitaxon10029 lung monolayers use mutant fail transform restrictive temperature confluent monolayers deplete medium use transform clone select purify recloning examine temperature cell line induced mutant lose transform phenotype high temperature function require maintenance transform phenotype ncbitaxon10029 lung cell function know require initiation viral dna synthesis permissive cell therefore transformation consequence introduction cell capacity aberrant initiation dna replication
163375	1975	function ncbitaxon1891767 gene transform infection productive infection ncbitaxon1891767 gene know regulate initiation viral dna replication control synthesis late viral rna function gene transform infection investigate infection variety cell specie six independently isolated temperature sensitive mutant belonging complementation group mutant fail initiate stable transformation cell continuous infection restrictive temperature establishment transformation permissive temperature subsequent shift restrictive temperature block function two distinct virus cell interaction identify one case increase colony form capacity transform cell remain stable temperature shift case temperature shift decrease capacity transform cell form colony level untransformed control cell outcome virus cell interaction depend nature mutation give cell specie specie cell transform give mutant finding suggest transformation process require two distinct event related gene expression
163376	1975	role ncbitaxon1891767 gene function maintenance transformation ncbitaxon10090 ncbitaxon10034 human cell transform permissive temperature mutant ncbitaxon1891767 ncbitaxon1891767 complementation group order ascertain role gene function transformation follow parameter transformation monitor transform cell permissive nonpermissive condition morphology saturation density colony formation plastic cell monolayers soft meshd000362 uptake meshd006601 expression meshd009369 surface antigen cell transform temperature sensitive t mutant exhibit phenotype transform cell nonrestrictive temperature parameter study grown restrictive temperature phenotypically similar normal untransformed cell growth curve show t mutant transform cell exhibit growth characteristic wild type virus transform cell permissive temperature resemble normal cell place restrictive condition 3 51 fold reduction level saturation density colony formation uptake meshd006601 mutant transform cell elevate temperature compare grown permissive temperature mutant transform cell nonpermissive temperature able produce transform focus shift permissive condition indicate phenotypically revert cell still viable reversion reversible event ncbitaxon1891767 antigen present cell temperature antigen detect cell maintain nonpremissive temperature wild type virus transform cell exhbited transform cell exhibit transform phenotype grown either restrictive nonrestrictive condition thers result indicate ncbitaxon1891767 group mutant transform cell temperature sensitive maintenance growth property characteristic transformation virus rescue mutant transform cell transfection method t suggest ncbitaxon1891767 gene function rather cellular one responsible t behavior cell
163377	1975	ncbitaxon1891767 gene function maintenance transformation transformants isolated infection ncbitaxon10116 embryo cell 33 either wild type ncbitaxon1891767 temperature sensitive gene mutant tsa7 tsa28 examination property usually associate transformation growth 1 serum growth rate saturation density morphology show property temperature dependent meshc012589 transformants characterize temperature dependent wild type transformants examine thoroughly characterize tsa transformants expression antigen appear temperature dependent data suggest active function require maintenance transformation cell lytic cycle function involve initiation dna synthesis transformation ncbitaxon1891767 direct consequence introduction ncbitaxon1891767 replicon presence dna initiator function cause cell express transform phenotype
163379	1975	detection virus specific antigen surface herpes simplex virus transform cell virion associate antigen cp 1 detect surface ncbitaxon10034 cell transformation inactivate ncbitaxon10298 presence cp 1 antigen cell correlate synthesis antibody tumorbearing hamster capable neutralize herpes simplex virus type 1 2
163380	1975	ectopic production ncbigene2056 meshd009396 patient relation clinical stage disease activity measurement ncbigene2056 level achieve urine plasma meshd009369 extract specimen 27 meshd009396 patient good correlation stage disease clinical judgment inactive respond meshc565785 ncbigene2056 level note ncbigene2056 level believe reflect ectopic hormone production primary secondary meshd009369 since ncbigene2056 hormone assayed meshd009396 patient associate meshd011086 believe meshd009396 associate ncbigene2056 differs manner hormone produce normally man possible state associate secondary meshd011086 etythropoietin assay purification technical development additional widespread assistance clinical classification subsequent management meshd009369 state study confirms biological potential
163448	1975	computerize axial tomography clinicopathologic correlation august 1973 april 1974 750 patient computerize axial tomography ct scan massachusetts general hospital ten brain previously ct scan patient group section plane scan nearly exact correlation found anatomic location extent intracranial lesion demonstrate ct scan finding gross microscopic pathologic examination case primary meshd001932 meshd006849 meshd002543 meshd007511 meshd002544 meshd010871 thermal burn meshd001927 determination absorption value mu 47 pathologically verify process show high absorption meshd002543 meshd002118 contain meshd009369 readily separable process basis mu value alone abnormal mu value primary meshd001932 meshd004487 meshd007238 difficult distinguish normal spinal fluid white matter
163453	1975	isolation herpes simplex virus cerebrospinal fluid meshd008587 two case meshd008581 report etiologic diagnosis establish isolation herpes simplex virus cerebrospinal fluid patient afebrile meshd001919 culture obtain one patient thought meshd007938 experience add others literature indicates value culture herpes simplex virus cerebrospinal fluid
163460	1975	odontogenic meshd018254 comprehensive study twenty new case twenty new case meshc538229 add literature bring total number report case 152 clinical radiographic microscopic finding case support previously report data lesion odontogenic meshd018254 benign lesion arises residual odontogenic epithelium treat conservatively indication lesion recur histogenesis lesion well origin esinophilic droplet material discuss
163461	1975	meshc538445 submandibular gland meshc538445 major salivary gland observe report literature often site origin primary meshd009369 skin mucosal line head neck structure meshd009369 commonly meshd008545 meshd002294 frequently involve salivary gland parotid submandibular sublingual gland rarely involve meshd004194 secondary lesion arise distant primary meshd009369 occasionally involve parotid gland extremely rare major salivary gland second report case metastatic meshd002277 submandibular gland present case previously report case similar primary meshd009369 originate breast clinical morphologic feature review
163487	1975	selection variant meshd016399 adenylate cyclase meshd007545 stimulator adenylate cyclase use select stable variant clone ncbitaxon10090 meshd008228 enzyme inability four different stimulators activate meshd000242 synthesis variant contrast wild type parent implies normal cell one type adenylate cyclase molecular respond different activator
163489	1975	primate type virus ncbigene201161 antigen cell human meshd015470 antigen related major structural protein ncbigene201161 type virus isolated ncbitaxon9519 ncbitaxon9581 ape found peripheral white blood cell five patient meshd015470
163501	1975	mesothelial reaction meshd001195 irritant intraperitoneal injection ten group ncbitaxon10116 inject intraperitoneally one follow suspension standard reference meshd017638 ii acid treat meshd017638 iii meshd017638 plus meshc000499 iv meshd017638 plus meshd012822 meshc000499 vi meshd012822 vii long fibre meshd017638 viii short fibre meshd017638 ix long fibre glass short fibre glass two ncbitaxon10116 group kill 45 90 150 240 330 day respectively pathology induced different suspension study histologically time interval evidence support chemical induction theory mechanical irritation theory pathogenesis peritoneal meshd008654 found although suspension except meshc000499 cause reactive mesothelium
163502	1975	technique result endoscopic retrograde pancreaticocholangiography preliminary report 140 patient endoscopic retrograde pancreaticocholangiography erpc perform 140 patient mainly black indian first 100 patient analyse great diagnostic yield series suspect obstructive meshd007565 26 diagnosis make 35 patient 40 patient meshd010195 wide duct see 12 patient meshc566837 procedure less help expect patient meshd010146 cessation meshd000438 intake found operable stricture main meshd021441 pancreatic function test secretin cholecystokinin pancreozymin correctly diagnose 4 patient meshc566837 erpc normal useful diagnostic yield patient meshd012817 15 diagnosis make 23 patient
163509	1975	ultrasound diagnosis meshd006869 due obstruction pelviureteric junction use ultrasonography diagnosis upper abdominal mass nonfunctioning kidney described two case congential meshd006869 due obstruction pelviuretic junction present diagnose scan ultrasound examination diagnostic ultrasound simple noninvasive reliable method differentiate cystic solid lesion assess whether mass renal extrarenal recommend patient see upper abdominal mass nonfunctioning kidney examine ultrasound
163515	1975	meshd016582 clinical effect ncbitaxon9685 meshd016582 common among ncbitaxon9685 contact high virus transmit readily ncbitaxon9685 cause variety haemopoietic meshd008223 common type alimentary multicentric thymic meshd015451 virus involve aetiology certain disease include meshd000740 meshd005921 meshd013577 predisposes ncbitaxon9685 intercurrent meshd007239 many infect ncbitaxon9685 mount immune response suffer immune status show serum antibody level feline meshd007938 virus associate cell membrane antigen ncbitaxon9685 titre 32 unlikely suffer ill effect eliminate meshd015658 outcome meshd007239 individual cat depends immunological competence cat dose virus receive ability induce immunosuppression ncbitaxon11768 meshd007239 detect examination tissue electron microscopy culture virus plasma tissue united state method use detection meshd007938 antigen peripheral blood leukocyte carry ordinary blood film successful prototype vaccine developed ncbitaxon11768 paper describes natural history virus disease implicate discus recently developed diagnostic method
163523	1975	mixed mullerian meshd009369 uterus ultrastructural study differentiation rhabdomyoblasts present study differentiation rhabdomyoblasts two meshd002296 uterus analyse electronmicroscopically development rhabdomyoblasts three cell type distinguish 1 undifferentiated mesenchymal cell abundant ribosome cell organelle usually cell already associate strand 2 4 cell occasionally cytoplasmic area numerous nonspecific filament observe 2 light rhabdomyoblast characterize conspicuous nonspecific cytoplasmic filament reduction ribosome specific myofilaments visualize occasionally cell type 3 differentiate rhabdomyoblasts cell identify clearly presence large number myofibril myofibrillar fragment higly organize myofibril see skeletal muscle seldom found transitional form cell type observe function body sarcotubular system process myofibrillar differentiation discuss
163559	1975	cytopathology metastatic meshd001943 comparison make histopathologic cytopathologic appearance 45 case metastatic meshd001943 histopathologic appearance primary meshd009369 metastatic infiltrate duct meshd002277 body cavity fluid present admixture single cell tissue fragment ratio 0 86 1 commonly occur tissue fragment well circumscribed round oval mass cell true acinus cell tandem arrangement cell metastatic infiltrate duct meshd002277 pleomorphic range 11 5 22 micrometer diameter metastatic infiltrate meshd018275 body cavity fluid present population primarily single cell ratio 13 single cell tissue fragment rare tissue fragment encounter group loosely cohesive cell nuclear mold cytoplasm adjacent cell individual cell extremely high nuclear cellular ratio uniform size range diameter 10 5 14 micrometer presentation metastatic infiltrate meshd018275 similar meshd008223 body cavity fluid cerebrospinal fluid pose problem differential diagnosis
163565	1975	virilize meshd018246 responsive gonadotrophin virilize meshd018246 demonstrate yound female urinary meshd015068 excretion subfractions plasma meshd013739 level urinary 17 ketogenic meshd013256 excretion markedly increase meshd003687 main constituent androgen excess otherwise meshd018268 found normal evaluate measurement meshd006854 meshd003345 metabolite basal condition dynamic test androgen excess show unexpected response trophic hormone human chorionic gonadotrophin stimulation result pronounce increase androgen production whereas gonadotrophin dependency demonstrate mean oestrogen suppression test similarly corticotrophin dependency demonstrate corticotrophin stimulation suppression test removal meshd009369 result normalization androgen production abnormal response upon human chorionic gonadotrophin administration found inappropriate response meshd009369 trophic hormone discuss conclude reliability stimulation suppression test determine site excessive androgen production accepted reservation
163566	1975	dissociation vivo vitro autonomy human meshd000306 diagnosis meshd003480 due meshd000306 establish patient appropriate examination especially meshd003907 suppression test ncbigene5443 stimulation test ncbigene5443 measurement radioimmunoassay isolated cell prepared piece meshd009369 trypsin technique action ncbigene5443 steriodogenesis cell study vitro basal production corticosteroid isolated meshd009369 cell low 0 3 mu plus minus 0 04 2 10 5 cell addition ncbigene5443 induced dose dependent stimulation corticosteroid production meshd009369 cell appear unable produce corticosteroid absence ncbigene5443 maximal production rather low 1 38 mu plus minus 0 07 2 10 5 cell possible explanation discrepancy endocrine function test result vitro study give
163571	1975	bronchiolo meshd002282 cell origin bronchiolo meshd002282 least common primary meshd008175 controversy cell origin light electron microscopic study five bronchiolo meshd002282 least two cell type found bronchiolar origin one cell type metaplastic bronchiolar mucous cell bronchiolar stem cell ultrastructural feature respiratory ciliated respiratory nonciliated clara cell unusual meshd009369 bronchiolo alveolar region differentiate cell either bronchiole alveolus embryologically common origin information ultrastructure meshd009369 accumulates become apparent meshd002282 must rare occurrence hyperplastic type ii aleveolar epithelial cell found margin meshd009369 mistaken neoplastic cell
163577	1975	role renal meshd000242 control ncbigene13856 production regulatory role meshd000242 meshd000242 production renal hormone rythropoietin follow erythropoietic stimulation cobaltous chloride hexahydrate propose study rate reveal temporal relationship renal meshd000242 level plasma titer ncbigene13856 addition meshd003035 increase activity ncbigene13856 generate enzyme renal erythropoietic factor maximal enzyme activity occur rise meshd000242 level increase ncbigene13856 titer increase renal meshd000242 localize renal cortex meshd003035 stimulates renal cortical adenylate cyclase effect renal cyclic nucleotide phosphodiesterase addition meshd000242 3 time 10 6 partially purify cyclic amp dependent protein kinase ncbitaxon10116 kidney inactive preparation renal erythropoietic factor increase ability renal erythropoietic factor generate ncbigene24335 data polycythemic ncbitaxon10090 assay bioassay use quantitate erythropoietic activity test substance indicate meshd003994 erythropoietically active respect ability increase radioactive label meshd007501 meshc000615388 incorporation meshd006418 newly form red blood cell meshd013806 erythropoietically inactive potentiate erythropoietic effect meshd003035 polycythemic ncbitaxon10090 result suggest meshd000242 play significant role renal production ncbigene13856 follow meshd003035 administration postulate meshd003035 stimulates renal cortical adenyoate cyclase increase renal meshd000242 level meshd000242 activates protein kinase subsequently stimulates renal erythropoietic factor generate ncbigene13856 similar meshd000242 mechanism operative erythropoietic stimulation exposure meshd000860 meshd011453 treatment
163581	1975	american meshd002051 clinicopathologic study 30 case ii pathologic correlation thirty case meshd008223 undifferentiated burkitt type review old median age predominance presentation abdominal pelvic site rather jaw distinguishes series american patient report endemic region africa bone marrow involvement invariably consist massive infiltration recognizable smear clot biopsy preparation involvement central nervous system meshd001855 always associate short survival eight long term survivor meshd008223 apparently confine single site presentation autopsy consistent find widespread multiorgan involvement predilection lymphoreticular structure histologic appearance meshd009369 change chemotherapy vary diffuse meshd009336 48 hour initial therapy extreme pleomorphism meshd009369 cell 9 month therapy one patient almost complete meshd004832 autopsy organ site show clinically extensively involve meshd009369 prior treatment diagnostic therapeutic implication finding discuss
163582	1975	clinical evaluation patient meshd007244 development antibody component epstein barr virus induced early antigen complex previous report emphasize transitory antibody response epstein barr virus ncbitaxon10376 induced early antigen ea course meshd007244 usually direct diffuse component ea complex report clinical serologic data present 14 patient meshd007244 respond either solely antibody restrict component ea complex reveal anti initial anti response subside week month onset disease anti persist usually many month many 39 patient longer detectable late follow serum spectimens although many patient unremarkable course illness others mostly late anti response show unusual protract clinical manifestation several complain period 4 28 month recurrent symptom resemble experienced acute stage disease presence anti relatively high continuous titer antibody eb viral capsid antigen vca reflect usual persistent ncbitaxon10376 activity turn account recurrent symptom
163583	1975	meshd005198 adult manifestation latent form meshd009101 review 17 case meshd005198 bence jones meshd011507 meshd009101 meshd000686 include three new case report detail emerges well define set characteristic case diagnosis meshd005198 precede development meshd000686 meshd009101 precede development meshd005198 report patient bence jones meshd011507 detect electrophoresis immunoelectrophoresis seven case bence jones protein typed kappa type serum protein monoclonal abnormality bone marrow renal sample half patient crystalline cytoplasmic inclusion body present lymphoplasmacytic element renal tubular cell propose patient meshd005198 bence jones meshd011507 distinct type plasma cell disorder variant monoclonal gammopathy characterize slow progression meshd009369 early phase dominate metabolic complication meshd005198 adult patient meshd005198 carefully investigate presence bence jones protein plasmacytic meshd010265 exclude
163584	1975	aberrant hormone activity meshd009369 gynecologic importance increase number meshd004701 report production hormonal substance generally associate tissue involve directly indirectly concern gynecologist identification occurrence important diagnosis meshd009382 meshd009369 effect addition observation level aberrant hormone secretion important therapeutic prognostic measure detection result investigation apparent inappropriate meshd004700 routine screen case know meshd009369 proof actual production hormone meshd009369 complete identification material question generally require extensive biologic chemical physical immunologic investigation likely mechanism aberrant hormone production meshd009369 derepression genome occurrence chance biosynthetic anomaly coincident neoplastic nuclear alteration endocrine active substance interest gynecologist produce circumstance include gonadotropin lactogen thyrotropin adrenocortico tropin well meshd002118 mobilize erythropoietic substance
163585	1975	ncbigene1084 patient gynecologic meshd009369 determination ncbigene1084 ncbigene1084 plasma much interest currently concomitant search immunologic diagnosis test recent report shed doubt specificity carcinoembryonic antigen meshd004067 report detail plasma ncbigene1084 value 341 patient vary gynecologic meshd009369 study demonstrate plasma ncbigene1084 elevate close 50 per cent patient invasive gynecologic meshd009369 incidence positive value appreciably high advanced stage disease particular interest 84 per cent 21 25 patient recurrent meshd002294 cervix positive ncbigene1084 value similar result found patient meshd009369 vulva ovary endometrium
163592	1975	human meshd050197 plaque cell meshd007889 cell comparison vitro growth characteristic cell derive human meshd050197 arterial medium compare cell obtain human meshc535516 myometrium respect growth behavior long term cell culture none numerous variation culture medium include alteration serum concentration source improve rate cell multiplication vitro longevity uterine cell type neither arterial cell type multiply tissue dissociation enzyme elastase collagenase hyaluronidase replicative life span eight sample arterial plaque cell equal less correspond medial cell similar relationship observe eight pair set meshd007889 myometrial cell result indicate condition culture vitro cell bona fide smooth meshd009217 finite replicative life span smooth muscle cell meshd050197 plaque behave similar manner
163597	1975	roentgen problem evaluate atrophic stomach elderly gastric meshd001284 elderly cause problem interpretation gastrointestinal study seventeen case report 8 patient show limited distensibility irregularity distal stomach simulate meshd002293 6 patient show meshd016055 2 patient show meshd016055 medium awareness phenomenon prevent serious error roentgen diagnosis
163611	1975	meshd007340 low circulate ncbigene3630 level diagnostic value ncbigene3630 measurement meshd007003 coexist low plasma immunoreactive ncbigene3630 concentration found 78 year old woman meshd007340 absolute ncbigene3630 level meshd007003 elevate 0 9 1 4 ng ml accounting 66 5 total circulate immunoreactive insulinlike material raise serum ncbigene3630 concentration together abnormal ncbigene3630 ncbigene3630 ratio prove critical importance establish diagnosis islet cell meshd009369 patient
163619	1975	mummify cutaneous mixed meshd009369 34 year old man unusual mummify cutaneous mixed meshd009369 developed shortly meshd014947 apocrine type meshd009369 cell pilar differentiation explain presence mummification
163621	1975	intracavitary cardiac extension meshd006528 acute meshd059446 62 year old man demonstrate angiographically due meshd009369 later prove metastatic meshd006528 resection meshd009369 result total symptomatic relief
163628	1975	histocompatibility antigen solid meshd009369 evaluate relation histocompatibility antigen phenotype solid meshd009369 hl type determine 633 meshd009369 patient compare 489 normal control hl a8 elevate patient meshd002294 meshd008545 meshd000230 high incidence occur patient meshd012468 67 v 17 normal control threefold increase hl a5 detect patient connective tissue meshd012509 28 incidence v 9 normal control antigen frequency vary analyze time diagnosis interval treatment find certain meshd009369 association increase frequency individual hl antigen give clue cause genesis meshd009369
163633	1975	islet cell meshd010190 thirty case meshd018273 diagnose memorial hospital study 17 male 13 female patient average age 44 year meshd009369 locate body tail pancreas 25 instance primary meshd009369 large 6 cm epigastric meshd010146 meshd007003 meshd007565 frequent primary clinical presentation morphological difference found function nonfunctioning meshd009369 size meshd009369 local tissue infiltration vascular invasion helpful absolute parameter aid differentiation benign meshd018198 twenty six patient metastatic disease time diagnosis liver regional lymph node bone peritoneum common site meshd009362 average survival 3 9 year cumulative five year survival rate 65
163642	1975	general aspect hydrophobic chromatography adsorption elution characteristic skeletal muscle enzyme degree substitution meshd012685 4 alpha alkylamines varied gel different hydrophobicity produce protein adsorbed critical hydrophobicity ca 10 12 alkyl residue meshd012685 sphere reach enzyme phosphorylase kinase phosphorylase phosphatase 3 5 camp dependent protein kinase glycogen synthetase phosphorylase successively adsorbed hydrophobicity meshd012685 increase capacity gel enzyme protein general increase exponentially reach plateau value function degree substitution indication restriction hydrophobic center give protein critical hydrophobicity need adsorb protein either otained manner elongation employ alkylamine constant degree substitution additonally hydrophobicity gel increase high binding force result desorption protein require augmentation meshd012492 concentration elution buffer elution protein hydrophobic matrix described term salt phenomenon since desorption dependent type meshd012492 employ ionic strength alone rule ionic interaction major factor adsorption per se rationally control hydrophobicity meshd012685 gel adsorption elution protein establised purification elimination optimally perform
163652	1975	dna binding protein novikoff meshd006528 cell 0 05 meshd012965 6 8 total soluble protein novikoff meshd006528 cell bind rapidly reversibly column contain either heterologous homologous dna adsorbed meshd002482 protein elute buffer contain 2 0 meshd012965 0 5 1 total protein exhibit 7 17 fold preference ncbitaxon10116 dna ncbitaxon562 dna 1 1 5 protein bind dna strongly elution effect 4 0 meshd012965 accomplish deoxyribonuclease treatment column dna binding protein elute 2 0 meshd012965 label 125i 131i characterize meshd012967 meshc016679 gel electrophoresis isoelectric focus experiment indicate dna binding protein represent discrete subset total soluble protein many similarity note major component homologous heterologous dna binding fraction
163656	1975	three dna polymerase ncbitaxon10116 meshd001201 cell property enzyme effect rna synthesis reaction three different dna polymerase isolated ncbitaxon10116 meshd001201 cell 1 3 molecular weight dna polymerase polymerase purify soluble fraction cell estimate 142 000 sedimentation meshd013395 gradient molecular weight two dna polymerase polymerase 1 2 purify nuclear membrane chromatin fraction estimate 117 000 44 000 respectively method certain condition meshd011071 strand meshc015465 meshd013936 copy well polymerase especially nuclear polymerase meshc023826 good template high molecular weight dna polymerase 1 meshd011071 meshc015465 effective template addition complementary meshd009843 single strand deoxypolymers copy high molecular weight polymerase 1 single strand fd phage dna use template polymerization reaction high molecular weight polymerase stimulate concomitant synthesis rna indicates oligoribonucleotide act primer reaction
163658	1975	human chronic meshd007951 cell line positive philadelphia chromosome cell line derive patient meshd015464 cml described new cell line 175 serial passanges 3 1 2 yr period follow characteristic 1 cml cell start proliferate actively since first incubate culture medium threefold increase total number cell observe first seven passage cell population increase factor 10 20 every 7 day passage 8 85 20 40 time passage 86 150 40 time 150 passage 2 majority nononucleated cell undifferentiated blast 3 karyotype cell examine show philadelphia ncbigene189 chromosome long acrocentric marker plus meshd000782 giemsa banding study identify ncbigene189 chromosome terminal deletion long arm chromosome 22 del 22 q12 long acrocentric marker unbalanced reciprocal translocation one chromosome 17 long arm one chromosome 15 4 cml cell produce immunoglobulin free meshd009175 epstein barr virus herpes like virus particle 5 cml cell alkaline phosphatase myeloperoxidase activity engulf inert particle 6 culture cml cell provide constant source specific antigen cml cell line represent unique source cml cell meaningful indicator meshd009369 clinical experimental study
163662	1975	ultrasound monitoring hepatic meshd009362 chemotherapy grey scale ultrasonography found sensitive method detect metastatic disease liver two case result chemotherapy monitor ultrasound response treatment distinguish non response ultrasonography give useful information chemotherapy make radioisotope examination unreliable
163673	1975	multiple chemotherapeutic approach management meshd018197 preliminary report 1970 stag base surgical resectability meshd056486 devise adjuvant chemotherapy meshd014750 meshd005472 meshd003520 give seven recent case objective study set unified clinical stag followup evaluate effect combination chemotherapy survival advanced disease evaluate early adjunctive combination chemotherapy surgically resectable lesion hopefully prevent metastasis result date seven patient change poor prognosis three female patient present stage iii iv meshd006528 three male stage ii meshd018197 do well survive free disease 47 month 44 month 28 month one patient meshd018197 lung metastasis diagnosis die 7 month meshd009369 meshd064420 note use adjunctive combination chemotherapy follow major hepatic resection
163675	1975	clinical trial oral form meshd005047 nsc 141540 vp 16 213 clinical trial oral form vp 16 213 nsc 141540 semisynthetic meshd011034 undertaken 20 patient treatment start 200 mg day 5 day course repeat rest period 16 day five patient treat dose repeat 9 day rest period subsequently 65 patient give 300 400 mg day 5 day rest period 9 day course side effect encounter include meshd000855 meshd009325 meshd014839 meshd013280 meshd003967 meshd007970 meshd013921 alopecia meshd011537 substernal discomfort palpitation report 18 patient explanation symptom found complete remission cr observe parital remission pr improvement imp see follow small cell meshd002277 lung 10 patient 2 pr 3 imp meshd000230 lung 4 patient 1 pr meshd002282 lung 1 patient 1 imp meshd008654 4 patient 1 imp meshd010051 12 patient 3 pr 3 imp meshd001943 20 patient 4 imp meshd015179 8 patient 2 imp meshd001749 4 patient 2 imp meshd016403 7 patient 2 pr 3 imp meshd015464 1 patient 1 imp
163676	1975	yoshi 864 nsc 102627 meshd000433 3 3 iminodi dimethanesulfonate ester hydrochloride phase 1 study yoshi 864 give push daily time 5 6 week followup dose escalation 0 25 mg kg 2 7 mg kg meshd064420 effectiveness first see 1 5 mg kg twenty five course give 16 patient level 16 22 course exclusive meshd015464 meshd013921 meshd007970 occur mean platelet wbc nadir occur day 24 29 recovery take 1 2 week 2 3 week respectively hb fell 11 course 2 7 mg kg meshd009325 meshd014839 last 6 12 day occur 3 7 course 5 coures patient slept 20 hour day 1 meshd003128 2 day two patient meshd002294 1 unknown primary respond patient meshd015464 clinical remission recommend cooperative phase ii study broad spectrum human meshd009369 include meshd008223 meshd015464 undertaken dose level 2 mg kg
163677	1975	meshd004194 child retrospective review clinicopathologic correlation dietary management clinicopathologic feature meshd004194 review 44 child receive whole abdominal radiation therapy 1961 1972 institut gustave roussy five 14 long term survivor 36 developed severe delayed meshd011832 meshd007409 occur 2 month completion irradiation previously acute radiation reaction therapy histologic appearance small bowel time delayed meshd011832 reveal severe meshd014949 lymphatic dilatation moderately dense inflammatory infiltrate patient delayed meshd011832 show marked clinical improvement coincident fractionate low residue low fat diet free gluten free milk milk product meshd015212 roentgenographs small bowel biopsy revert normal appearance association diet exacerbation meshd004194 see follow dietary therapy
163678	1975	meshd009396 meshc538614 patient meshd013724 contain meshd009396 meshc538614 described rarity renal tissue meshd013724 possible mode development meshd009396 meshc538614 meshd009369 discuss
163679	1975	syndrome meshd005877 meshd007674 meshc536399 meshd009396 new case fetal meshc536399 described meshd009396 occur consider observation provide strong evidence interrelationship meshd007674
163680	1975	synovial meshd012509 neck followup study 24 case article review clinicopathologic feature biological behavior 24 case meshd013584 take origin cervical prevertebral connective tissue space manifest meshd017703 palpable mass anterior posterior cervical triangle age 24 patient range 10 51 year median 19 year ten patient woman 14 men hoarseness difficulty breathing swallow first symptom eight patient meshd009369 solitary range 2 10 cm great dimension microscopically case show characteristic biphasic cellular pattern meshd013584 epithelioid meshd005354 like area vary proportion synovioblastic origin meshd009369 confirm result histochemical stain procedure 1 case examination electron microscope 21 case followup information 12 die 10 meshd009362 9 alive free symptom prompt complete surgical removal require prevent complication recurrent meshd009369 growth metastasis
163681	1975	specific estrogen binding ncbitaxon10116 mammary meshd009369 induced 7 12 dimethylbenz meshc034020 experiment undertaken 7 12 dimethylbenz meshc034020 induced mammary meshd009369 ncbitaxon10116 determine whether meshd010051 distinguish basis difference estrogen binding capacity meshd009369 vitro vivo result confirm report show meshd010051 undergo interaction meshd010051 undergo interaction 17beta 3h estradiol specific estrogen binding component vivo vitro described estrogen target tissue result demonstrate certain 7 12 dimethylbenz meshc034020 induced meshd009369 continue grow ovariectomy host contain significant amount 17beta 3h estradiol bound cytoplasmic well nuclear component sedimentation property component indistinguishable either ovarian dependent 7 12 dimethylbenz meshc034020 induced meshd009369 ncbitaxon10116 uterus cytoplasmic binding component class meshd009369 exhibit similar specificity estrogen appear absolute correlation estrogen binding capacity meshd009369 growth response ovariectomy
163682	1975	autoantibody antilipoprotein specificity meshd007009 patient meshd009369 serum 151 patient variety meshd009369 screen antibody like activity lipoprotein eighteen serum exhibit activity autologous homologous high density lipoprotein 3 exhibit activity autologous homologous low density lipoprotiens antibody like binding proven restriction ncbigene2187 fragment igg reactive part lipoprotein molecule show appoprotein quantiation serum lipoprotein indicate thehigh density lipoprotien concentration serum meshd009369 patient significantly low psmaller 0 01 antibody present observation suggest autoimmune mechanism responsible decrease high density lipoprotein serum level patient meshd009369
163683	1975	glycosaminoglycans human meshd008113 method propose analysis meshd006025 isolated human liver combine meshc005062 electrophoresis enzymatic digestion mucopolysaccharidases major constituent glycossaminoglycans healthy liver meshd006497 meshd006493 65 approximately equal quantity meshd003871 hyalauronic acid 13 5 13 respectively small amount meshd002809 component especially meshd002809 meshd006820 markedly increase meshd056486
163684	1975	blastomogenic activity meshc001418 ncbitaxon10090 blastomogenic activity meshc001418 establish prolong administration c57bl 6 cc57br ncbitaxon10090 meshc017648 test blastomogenic condition preparation aqueous solution inject dorsal region twice weekly 1 5 mg dos total dose per ncbitaxon10090 42 mg meshc001418 50 mg meshc017648 resorptive character many form blastomogenic activity hydroxphenyllactic acid show induced meshd009369 varied histogenesis meshd007938 meshd000236 meshd006528 meshd009369 vascular tissue include benign meshd018198 meshd011230
163685	1975	comparative adenylate cyclase activity homogenate plasma membrane fraction meshd008114 5123tc homogenate plasma membrane fraction meshd008114 5123tc ncbitaxon10116 liver study regard relative basal activties adenylate cyclase comparative responsiveness enzyme meshd005934 meshd012969 meshd004837 meshd000527 insulin basal adenylate cyclase activity meshd006528 found similar liver adenosine 5 triphosphate concentration 3 2 mm substrate affinity km adenosine 5 triphosphate meshd009369 enzyme comparable liver finding suggest reduce basal cyclic adenosine 3 5 monophosphate level found occur meshd006528 5123tc probably due decrease basal rate formation cyclic nucleotide meshd005934 5 6 mum significantly stimulate adenylate cyclase fraction meshd006528 liver responsiveness meshd009369 enzyme hormone substantially low responsiveness liver homogenate plasma membrane preparation activity enhance 18 fold relative basal activity liver homogenate compare 6 fold increase meshd009369 plasma membrane preparation meshd005934 increase activity 5 3 5 fold liver meshd006528 respectively meshd012969 10mm contrast meshd005934 increase adenylate cyclase activity approximately extent 10 fold liver meshd006528 preparation meshd004837 100 mum enhance liver meshd006528 homogenate activites 3 4 fold meshd006528 plasma membrane activity 2 fold liver plasma membrane activites increase meshd000527 56 6 mum significantly increase adenylate cyclase activites meshd006528 homogenate 1 5 3 fold respectively plasma membrane preparation insulin 0 7 mum significantly alter adenylate cyclase activity preparation
163686	1975	increase activity low km cyclic adenosine 3 5 monophosphate phosphodiesterase plasma membrane meshd008114 5123tc total cyclic adenosine 3 5 monophosphate camp phosphodiesterase activity well activity low high enzyme form investigate homogenate 100 000 supernatant plasma membrane fraction ncbitaxon10116 liver meshd008114 5123tc responsiveness meshd006528 liver plasma membrane low phosphodiesterases imidazole 40 mm theophylline 5mm compare camp concentration 1 7 5 mum total camp phosphodiesterase activity meshd009369 homogenate 100 000 supernatant fraction found less one half liver kinetic study homogenate indicate find largely due substantial reduction 53 activity meshd006528 high enzyme contrast low km camp phosphodiesterase activity meshd009369 homogenate plasma membrane fraction significantly 50 high liver particularly evident meshd000242 concentration 0 5 2 mum since concentration range basal physiological level meshd000242 hepatocytes present result suggest reduce level meshd000242 previously observe meshd006528 5123tc primarily due to increase rate meshd000242 metabolism low km meshd000242 phosphodiesterase plasma membrane meshd009369 meshc029899 increase activity low camp phosphodiesterase liver plasma membrane 22 1 mum meshd000242 38 7 5 mum meshd000242 meshd009369 activity enhance 35 50 respectively 1 7 5 mum meshd000242 meshd013806 inhibit plasma membrane phosphodiesterase activity liver 79 53 meshd000242 concentration 1 7 5 mum respectively meshd006528 activity inhibit 82 1 mum meshd000242 62 7 5 mum meshd000242
163687	1975	estrogen ncbigene5617 dependency 7 12 dimethylbenz meshc034020 induced meshd009369 hormonal influence dimethylbenz meshc034020 induced meshd009369 growth investigate detail endocrine ablation replacement hormone majority meshd009369 regress follow ablation reactivate subsequent administration estrogen 0 1 5 mug ncbigene5617 2 mg increase number meshd009369 stimulate ncbigene5617 administration delayed basal level meshd004958 0 01 mug addition ncbigene5617 require reactivation meshd009369 meshd009256 competitor estrogen receptor site arrest growth large portion dimethylbenz meshc034020 induced meshd009369 intact animal fail retard growth ncbigene5617 stimulate meshd009369 withdrawal ncbigene5617 meshd009256 rapid regression meshd009369 occur readministration ncbigene5617 fail activate meshd009369 long 28 day result give good support evidence estrogen play primary role meshd009369 growth interaction ncbigene5617 estrogen meshd009369 site necessary regulatory event related meshd009369 growth
163688	1975	alteration ncbigene25134 activity fetal adult meshd009369 tissue ncbigene25134 activity examine number fetal adult organ well several rodent meshd006528 use enzymatic immunological technique fetal ncbitaxon9986 liver activity first appear low level 20 day postfertilization rise high level birth reach maximum adult liver fast grow meshd006528 activity detect either enzymatic immunological assay detect slow grow meshd006528 considerably diminish level compare normal adult ncbitaxon10116 liver immunoassay give evidence inactive form enzyme tissue enzymatic activity transfer rna methyltransferase assay carry simultaneously show inverse relationship ncbigene25134 activity level transfer rna methyltransferase activity high fetal meshd009369 tissue low normal adult tissue
163689	1975	identification virion vitro l1210 meshd007938 cell line morphological virological immunological technique vitro l1210 cell line contain abundant intracytoplasmic particle numerous type particle small number type particle occasional intracisternal particle intracytoplasmic particle incorporate spike type smooth surface type particle form budding site type particle developed gradual accululation neucleooid material particle particularly type exhibit wide range density cell show strong surface immunofluoresence ncbitaxon10090 mammary meshd009369 virus gross ncbitaxon11786 antigen variable degree cytoplasmic immunoflurescence protein antigen p1 p6 meshd007938 cell culture supernatant purify virus give positive reaction ncbitaxon10090 mammary meshd009369 virus ncbitaxon11786 antiserum immunodiffusion viral particle fail infect c57bl c57bl 6 dba 2f1 hereafter call bd2f1 balb af riiif ncbitaxon10090 howver cell highly tumorigenic bd1f 1 ncbitaxon10090 moderately tumorigenic balb ncbitaxon10090 tumorigenic c57bl af riiif ncbitaxon10090
163690	1975	comparison effect meshd003630 meshd004317 various dna polymerase effect meshd018943 antiboties meshd003630 meshd004317 dna direct activity dna polymerase ncbitaxon11809 ncbitaxon10116 liver high molecular weight specie ncbitaxon562 ncbitaxon1270 determine condition test compound great inhibitory effect viral polymerase cellular polymerase inhibition ncbitaxon11809 dna polymerase meshd003630 competitive respect dna viral dna polymerase conclude inhibition predominatly cause interaction duanomycin primer template dna appreciable reversal meshd003630 induced inhibition polymerase increase mg 2 concentration consistent conclusion derive competition experiment contrast inhibition ncbitaxon10116 liver ncbitaxon1270 dna polymerase essentially noncompetitive dna bacterial enzyme wer less sensitive inhibition drug virion polymerase strong preferential inhibiton viral dna polymerase discuss relation differential sensitivity normal compare meshd009369 cell observe cell line
163691	1975	heritability phytohemagglutinin responsiveness lymphocyte relationship leukemogenesis upon analysis 59 inbred strain 1 hybrid congenic resistant ncbitaxon10090 strain strain distribution pattern stimulation perippheral ncbitaxon10090 lymphocyte phytohemagglutinin establish use micromethod family dba ncbitaxon10090 low responder phytohemagglutinin whereas c57 family respond best strain pl exhibit best response response lymphocyte lectin govern two less five major gene unknown linkage direct association 2 histocompatibility complex found although indirect influence locus exclude high meshd007938 strain good responder phytohemagglutinin none low responder group strain exhibit spontaneous meshd007938 correlation response lymphocyte expression type rna genome establish cell suspension animal exhibit clinical sign meshd007938 respond weakly lectin
163692	1975	benzo alpha pyrene effect ncbitaxon10090 epithelial cell culture effect meshd001564 growth culture 5 ncbitaxon10090 epithelial cell strain examine epithelial cell highly sensitive cytotoxic action meshd001564 addition activity benzol meshc030984 metabolize system aryl hydrocarbon hydroxylase low highly iducible carcinogen sensitivity cell strain cytotoxic action benjo pyrene decrease inudcibility hydroxylase decrease strong correlation found meshd064420 level uninduced induced hydroxylase value different cell strain compare experiment suggest thehydroxylase important determine sensitivity epithelial cell cytotoxic action meshd001564 factor modulate sensitivity
163693	1975	peptidyl proline hydroxylase adult develop neoplastic ncbitaxon10116 tissue sensitive assay system optimally supplement tritiated protocollagen substrate cofactor described suitable determine peptidyl proline hydroxylase pph content wide spectrum ncbitaxon10116 tissue tissue less 50 percent total activity soluble particulate portion activity concentrate mitochondrial microsomal fraction double pretreatment meshd017830 among normal adult tissue lung high total pph activity 2 4 time liver small intestine low 25 percent liver brain lactate mammary gland activity similar skin 60 percent liver fetal tissue contain 3 8 time pph correspond adult tissue much low portion total activity soluble four tissue study detail lung liver kidney brain total pph decline rapidly last day gestation brain attain low adult value term whereas three tissue continued decrease course postnatal development injection cortisol fetal ncbitaxon10116 enhance decline pph lung liver skull experiment suggest normal differentiation decline collagen synthesis initiate fetal glucocorticoid secretion maximal 19th gestational day pph activity appear sensitive indicator neoplastic growth renal mammary muscle meshd056486 pph activity 4 10 time high cognate adult tissue even well differentiate slowgrowing meshd009369 activity considerably high normal mature immature tissue exception skull lung 19 day old fetus
163694	1975	comparison immunogenicity ncbitaxon10034 cell transform adenovirus herpes simplex virus hamster vaccinate adenovirus transform cell modify acetoacetylation concanavalin treatment small number living cell partly completely protect challenge 3 time 10 6 living cell treatment vaccine cell meshd007461 meshd016685 neuraminidase plus meshd016685 produce efficient vaccine herpes simplex virus transform cell treat procedure prevent frequently even enhance growth homologous living cell enhancement often great female male hamster protective enhance vaccine induce different level cell mediate immunity detect lymphocytotoxicity test positive homologous transform cell nontransformed ncbitaxon10034 cell contrast specific complement dependent cytotoxic antibody active adenovirus transform cell induced protective acetoacetylated vaccine prepared adenovirus transform cell antibody present nonprotective vaccination appearance herpes simplex meshd014412 delayed treatment immunostimulant meshd007978 preimmunization ncbitaxon11176 grown sv40 transform cell ncbitaxon11176 grown herpes simplex virus transform cell nonspecific treatment able impede herpes simplex virus meshd009369 growth protection meshd000257 accompany specific cytotoxic antibody
163697	1975	regulation ncbigene25044 ncbigene25634 hyperplastic nodule ncbitaxon10116 liver meshd004052 meshd015073 feed change level ncbigene25044 ncbigene25634 induced dietary stimulus starvation hyperplastic nodule ncbitaxon10116 liver meshd004052 meshd015073 feed study immuno enzyme histochemical method study perform carcinogenesis combine method enzyme histochemistry radioautography ncbigene25044 observe diffusely cytoplasm original hepatocytes periportal zone induced markedly diethynitrosamine feed slightly meshd015073 feed enzyme deficient inducible hyperplastic nodule develop phase later feed period elevation level ncbigene25044 inducibility time majority nodule good correlation observe ncbigene25044 ncbigene25634 elevate level response enviornmental stimulus minor group hyperplastic nodule deficiency enzyme persist enzyme induction observe great number hyperplastic nodule persistent meshd008661 see meshd004052 carcinogenesis result provide information change biological nature hyperplastic nodule respect metabolic adaptability enzyme level meshd063646
163698	1975	physicochemical characterization novikoff meshd006528 mitochondrial dna mitochondrial dna mtdna isolated ncbitaxon10116 liver novikoff meshd006528 grown solid meshd009369 cell monolayer culture examine variety physicochemical technique buoyant density analytical meshc028019 equilibrium gradient thermal denaturation profile reveal significant difference base composition among mtdna isolated liver meshd009369 meshd006528 cell sedimentation neurtral alkaline cscl show difference mtdna size meshd009369 meshd006528 cell mtdna slightly small heterogeneous size liver mtdna molecular contour length measure electron microscope base chemical determination neoplastic mitochondrion contain four five time dna per mitochondrion liver electron microscopy show proportion mtdna complex form catenate dimer oligomers much high meshd009369 18 meshd006528 cell 15 liver 4
163699	1975	presence ncbigene3005 degree human tissue histone hidegree found present number human tissue constitute 50 total 5 meshc576518 soluble histone human breast 35 thyroid 12 18 adrenal 7 parathyroid tissue quantity histone hldegree human tissue large compare amount found ncbitaxon10116 liver 8 ncbitaxon9913 thymus 0 hela cell 0 although quantity histone hldegree found vary one type tissue another essentially constant normal hyperplastic neoplastic human thyroid tissue
163700	1975	ncbigene24683 estrogen binding transplantable hormone dependent autonomous ncbitaxon10116 mammary meshd002277 hormone dependent subline transplantable ncbitaxon10116 mammary meshd009369 mtw9 contains binding site ncbigene24683 estrogen ncbigene24683 binding saturable similar 2 time 10 9 hormone specific destroyed protease contrast autonomous subline derive parent meshd009369 lose 75 ncbigene24683 estrogen binding site although binding affinity hormone unchanged reduction binding site ncbigene24683 estrogen autonomous line result incomplete recognition meshd009369 cell target circulate hormone subsequent loss hormone dependent growth characteristic
163718	1975	control phosphorylative activity human liver mitochondrion change respiratory enzyme content 1 oxidative phosphorylation respiratory enzyme activity measure mitochondrion non involve lobe liver eighteen patient massive meshd009369 mainly localize one lobe regenerate liver partially hepatectomized ncbitaxon10116 treat meshd002701 2 patient concentration cytochrome varied 40 170 pmol mg protein mitochondrion cytochrome concentration 70 pmol mg protein phosphorylative activity per mg mitochondrial protein considerably high control mitochondrial oxidative phosphorylative activity per unit cytochrome negatively correlate concentration cytochrome patient mitochondrial cytochrome exceed 70 pmol mg protein tolerate partial hepatectomy well hand patient mitochondrial cytochrome less 60 pmol mg protein phosphorylative activity low high surgical mortality 3 regenerate liver ncbitaxon10116 treat meshd002701 oxidative phosphorylative activity per unit cytochrome negatively correlate concentration cytochrome 4 suggest increase meshd000255 synthesize activity per unit respiratory assembly basic homeostatic mechanism maintain energy production response increase metabolic load upon hepatic cell
163724	1975	use macrophage electrophoretic mobility test diagnosis meshd016543 author transl macrophage electrophoretic mobility mem test field caspary demonstrates ncbigene10216 ncbigene10216 produce specifically sentised blood lymphocyte incubation homologous antigen besides disease cellular immune reaction like multiple meshd009369 show reduction macrophage mobility cell electrophoresis significant inhibition mem test found 30 33 meshd009369 cns meshd005909 meshd001254 meshd008527 meshd004806 meshd009442 meshd008577 meshd005350 show positive result 10 inhibition result meshd009369 meshd010911 meshd003397 differ secondary meshd001932 show great inhibition
163727	1975	vaso active intestinal polypeptide meshd003969 40 year old man meshd003969 refractory watery meshd003967 islet cell meshd010190 islet cell meshd002277 non cell type meshd009362 liver mesenteric lymph node high concentration ncbigene7432 ncbigene7432 demonstrate meshd009369 tissue plasma radioimmunological test surgical removal meshd009369 plasma ncbigene7432 concentration fell normal immunohistochemical test meshd009369 meshd005767 hormone demonstrate marked fluorescence vaso active intestinal polypeptide assume polypeptide largely responsible clinical sign described case severe watery meshd003967 cease glucocorticoid administration
163735	1975	change endocrine property transplantable multihormonal meshd010911 mtt f4 hypophysectomy host ncbitaxon10116 transplantable ncbitaxon10116 meshd010911 meshc070243 f4 fail grow ncbitaxon10116 hypophysectomize time transplantation grow meshd013974 treat hypophysectomize ncbitaxon10116 latter ncbitaxon10116 meshd009369 stimulate adrenal extent control ncbitaxon10116 meshd009369 stimulate adrenal extent control ncbitaxon10116 meshd009369 cell isolated incubate vitro hypophysectomize meshd013974 treat ncbitaxon10116 release much less acth incubation medium meshd009369 cell control ncbitaxon10116 release significantly less growth hormone meshd009369 cell intact intact meshd013974 treat thyroidectomized meshd013974 treat ncbitaxon10116 prolactin release isolated meshd009369 cell vitro group study result suggest hypophysectomy meshd013974 treatment host ncbitaxon10116 selectively influence production hormone meshc070243 f4 transplantable ncbitaxon10116 meshd010911
163742	1975	effect fast control meshd005227 synthesis meshd006528 7777 host liver role long chain meshd000214 mitochondrial citrate transporter pyruvate dehydrogenase activity effect fast rate meshd005227 synthesis property mitochondrial citrate transporter pyruvate dehydrogenase activity investigate poorly differentiate meshd006528 7777 host liver preparation property citrate transporter meshd006528 similar meshd008107 exception km liver mitochondrial citrate transporter 248 plus minus 20 mu meshd006528 less 75 mu acid insoluble coa content 180 plus minus 20 pmol mg protein meshd006528 remain essentially unchanged fast state acid insoluble coa level liver fed ncbitaxon10116 720 plus minus 80 pmol mg protein increase 1050 plus minus 50 pmol mg protein fast 36 fast rate lipogenesis percentage pyruvate dehydrogenase present active form decrease approximately 80 host liver preparation contrast rate lipogenesis meshd006528 slice decrease fast essentially pyruvate dehydrogenase present active form meshd006528 obtain either fed fast animal implication concern identification possible regulatory site control lipogenesis discuss relation observation
163780	1975	relationship serum ncbigene174 severity duration meshd002908 patient meshd006525 use radioimmunoassay detect concentration ncbigene174 low 5 ng per ml 38 176 patient meshd006525 compare health volunteer patient meshd002908 affect liver separate two group base histological classification liver biopsy specimen difference degree frequency increase serum ncbigene174 related severity meshd056486 75 patient lesion viral subacute meshd047508 zone meshd009336 bridge adjacent portal triad central vein 52 increase value 12 level range 500 3300 ng per ml contrast 28 101 patient bridging meshd009336 increase value none level exceed 500 ng per ml patient subacute meshd047508 comparison ncbigene174 concentration duration meshd002908 indicate protein rise peak level serum sgot decline confirm serial observation 10 patient increase ncbigene174 serum patient severe meshd056486 occurs meshd017093 subside due know feature ncbigene174 intrigue speculate increase serum level protein meshd006525 reflect hepatic regeneration parenchymal damage
163793	1975	naturally occur persistent feline meshd004832 healthy ncbitaxon11768 ncbitaxon11768 infect ncbitaxon9685 meshd003027 environment follow 23 month development disease evidence alteration hemogram incidence disease development ncbitaxon11768 postive ncbitaxon9685 fivefold high incidence ncbitaxon11768 negative ncbitaxon9685 ten case meshd007938 developed 69 infect ncbitaxon9685 whereas one case meshd007938 occur 59 uninfected ncbitaxon9685 incidence development disease meshd007938 30 4 percent ncbitaxon11768 infect ncbitaxon9685 oppose 6 8 per cent uninfected ncbitaxon9685 result immunosuppressive effect ncbitaxon11768 ncbitaxon11768 infect ncbitaxon9685 evidence subclinical meshd000740 mean packed cell volume total leukocyte count infect uninfected animal variation see healthy ncbitaxon11768 infect ncbitaxon9685 decrease mean lymphocyte count difference mean lymphocyte count ncbitaxon11768 infect uninfected animal significant 0 999 level finding suggest incubation period feline meshd007938 prolong natural condition increase susceptibility unrelated meshd003141 exists period increase susceptibility apparently associate meshd000740 meshd000275 total leukocyte count
163824	1975	meshd011732 dependent conformational state glycogen phosphorylase probed interconverting enzyme interaction meshd011732 convertible meshd012694 glycogen phosphorylase investigate use specific interconverting enzyme phosphorylase kinase phosphorylase phosphatase effector meshd005947 meshd019298 protein kinase trypsin phosphorylase kinase phosphorylase phosphatase utilized native protein little influence apoprotein removal peptide contain critical meshd012694 residue give phosphorylase meshd011732 phosphorylase important effect enzymic interconversion
163829	1975	hapten sandwich label ii immunospecific attachment cell surface marker suitable scan electron microscopy hapten sandwich procedure use immunospecific label cell surface antigen marker visible scan electron microscopy antihapten antibody use link hapten modify ncbitaxon12242 bushy stunt virus hemocyanin hapten modify human erythrocyte antihapten antibody bridge use link hapten virus marker hapten modify antibody mammary meshd009369 virus ncbitaxon10090 mammary meshd009369 cell immunoglobulin receptor ncbitaxon10090 splenic lymphocyte case label highly specific technique possible compare morphological feature cell bearing differ cell surface antigen examine arrangement specific antigenic site cell surface distribution relative membrane structure microvilli
163832	1975	cell surface change rous sarcoma virus gene expression synchronize cell investigate whether cell surface change associate growth control malignant transformation link cell cycle ncbitaxon9031 embryo cell synchronize double meshd013936 block examine cell cycle dependent alteration membrane function measure transport meshd003847 meshd014529 meshd013936 meshd008353 cell surface morphology examine scan electron microscopy ability meshd009369 virus gene expression induce transformation specific change membrane function reach follow conclusion high rate meshd003847 transport see transform cell low rate meshd003847 meshd014529 transport characteristic density inhibit cell occur normal grow cell traverse cell cycle although cell cycle dependent change surface morphology reflect correspond change membrane function tumor virus gene expression alter cell membrane function stage cell cycle progression cell cycle
163841	1975	interaction delta 5 androstene 3beta 17beta diol meshd004958 dihydrotestosterone receptor human myometrial mammary meshd009369 tissue specific receptor binding meshd004958 ncbigene106478911 meshd013196 meshd013196 study human myometrial tissue human mammary meshd009369 tissue inhibition binding ncbigene106478911 dht ncbigene106478911 meshd013739 meshd013196 dehydroepiandosterone dhea meshd019314 ncbigene6822 meshd000735 5 androstene 3beta 17beta diol adiol test use meshd003911 coat charcoal separation bound free ncbigene106478911 respectively meshd013196 percentage binding inhibition calculate reference inhibition obtain meshd009256 molar concentration ratio 1 000 ncbigene106478911 binding respectively meshd017373 molar concentration ratio 10 000 meshd013196 binding 15 sample myometrium test receptor found ncbigene106478911 19 sample mammary meshd002277 tissue one show binding activity three sample bind ncbigene106478911 five sample meshd013196 ten sample show binding meshd013256 50 inhibition ncbigene106478911 binding myometrial well meshd009369 tissue require molar concentration ratio 40 adiol 2 000 dhea significant inhibit activity found molar concentration ratio 10 000 ncbigene6822 40 000 regard meshd013196 binding meshd015114 active ncbigene106478911 less active substance test meshd015114 therefore one exerts significant inhibit influence molar ratio far beyond physiological range signifies adiol interfere receptor level estrogenic stimulation mammary meshd009369 cell
163842	1975	regulation human ncbigene93659 secretion serum meshd003994 malignant trophoblast cell vitro human ncbigene93659 secretion study human malignant trophoblast cell jar line continuous culture radioimmunoassayable ncbigene93659 cell daily culture fluid increase least 3 day 10 newborn ncbitaxon9913 serum 1 mn 6 0 2 dibutyryl cyclic adenosine 3 5 monophosphoric acid dbcamp plus 1 mm theorphylline incubation cell presence serum dbcamp theorphylline result additive stimulation ncbigene93659 secretion 1 day 2 3 day supra additive stimulation observe prevent meshd003609 cell preincubated 2 day absence serum dbcamp plus theorphylline subsequent addition serum result supra additive stimulation ncbigene93659 secretion single day continued presence dbcamp plus meshd013806 necessary stimulation serum finding suggest dbcamp activates slow process require rna synthesis result increase ncbigene93659 secretion serum appear protect ncbigene93659 synthesize system degradation
163843	1975	immunochemical heterogeneity calcitonin plasma calcitonin measure plasma 13 patient medullary throid meshd002277 one patient calcitonin produce islet cell meshd010190 hormone measure simultaneous application two calcitonin antiserum differ specificity calcitonin measurement make gel filtration bio gel p30 fraction plasma sample although two antiserum comparable sensitivity measurement human calcitonin standard react differently calcitonin plasma sample one antiserum ld 1 give consistently high estimation hormone concentration plasma patient medullary meshd013964 ld 26 contrast concentration calcitonin islet cell meshd010190 high ld 26 assay multiple gel filtration peak immunoreactive calcitonin activity present thyroidal nonthyroidal calcitonin two different antiserum identify differ immunochemical peak calcitonin activity agiven plasma sample finding demonstrate presence immunochemical heterogeneity plasma calcitonin suggest presence immunological difference thyroidal nonthyroidal calcitonin
